High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients-Reference-Cited by-同舟云学术

High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients

Published:2011-03-27 Issue:6 Volume:25 Page:867-869
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Cotter Aoife G,Satchell Claudette S,O'Halloran Jane A,Feeney Eoin R,Sabin Caroline A,Mallon Patrick WG

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference9 articles.

1. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome;Grunfeld;J Clin Endocrinol Metab,1992

2. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?;Klein;J Acquir Immune Defic Syndr,2002

3. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy;Riddler;HIV Med,2007

4. A general cardiovascular risk profile: the Framingham Study;Kannel;Am J Cardiol,1976

5. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions;Zheng;Proc Natl Acad Sci USA,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Cardiovascular Risk Profile and Risk Scores of Antiretroviral Therapy-naïve HIV Patients in Eastern India;Journal of Global Infectious Diseases;2024-08-07

2. Executable models of immune signaling pathways in HIV-associated atherosclerosis;npj Systems Biology and Applications;2022-09-21

3. Executable models of immune signaling pathways in HIV-associated atherosclerosis;2022-03-07

4. Prevalence of Cardiometabolic Risk Factors Among People Living with HIV in Southern Texas;AIDS Research and Human Retroviruses;2021-11-01

5. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy;Frontiers in Immunology;2019-06-19